Simvastatin induces apoptosis of fibroblast-like synoviocytes

Open Rheumatology Journal

Volumn 3, Issue , 2009, Pages 35-40

  Litinsky, Ira ^a   Golan, Itshak ^a   Yaron, Michael ^a   Yaron, Ilana ^a   Caspi, Dan ^a   Elkayam, Ori ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Fibroblast like synoviocytes; Inflammation; Simvastatin

Indexed keywords

LIPOCORTIN 5; LIPOPOLYSACCHARIDE; SIMVASTATIN; TETRAZOLIUM;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOARTHRITIS; PRIORITY JOURNAL; SYNOVIOCYTE; SYNOVIUM; TOTAL KNEE REPLACEMENT;

EID: 77953440097     PISSN: None     EISSN: 18743129     Source Type: Journal    
DOI: 10.2174/1874312900903010035     Document Type: Article

References (35)

1. Aguilar-Salinas SA, Barrett H, Schonfeld G. Metabolic modes of action of statins in the hyperlipoproteinemias. Atherosclerosis 1998; 141: 203-7.
2. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998; 279: 1615-22.
3. Case CC, Ballantyne CM. Statins and inflammatory markers. Curr Atheroscler Rep 2002; 4: 42-7.
4. Bilchick KC, Henrikson CA, Skojec D, Kasper EK, Blumenthal RS. Treatment of hyperlipidemia in cardiac transplant recipients. Am Heart J 2004; 148: 200-10.
5. McCarey DW, McInnes IB, Madhok R, et al. Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomized placebo-controlled trial. Lancet 2004; 363: 2015-21.
6. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-Reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344: 1959-65.
7. Ridker PM, Rifai N, Lowenthal SP. Rapid reduction in C-reactive protein with cervastatin among 785 patients with primary hypercholesterolemia. Circulation 2001; 103: 1191-3.
8. Torborn H, Andreassen AK, Ueland T, et al. Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients. Am J Cardio 2001; 87: 815-18.
9. Rosenson RS, Tangney CC, Casey LC. Inhibition of proinflammatory cytokine production by pravastatin. Lancet 1999; 353: 983-84.
10. Jury EC, Ehrenstein MR. Statins: immunomodulators for autoimmune rheumatic disease? Lupus 2005; 14: 192-6.
11. Gay S, Gay RE, Koopman WJ. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction. Ann Rheum Dis 1993; 52: S39-S47.
12. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995; 96: 1631-38.
13. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995; 16: 39-43.
14. Cafforio P, Dammacco F, Gernone A, Silvestris F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 2005; 26(5): 883-91.
15. Muck AO, Seeger H, Wallwiener D. Class-specific pro-apoptotic effect of statins on human vascular endothelial cell. Z Kardiol 2004; 93: 398-402.
16. Castor CW, Bignell MC, Hossler PA, Roberts D. Connective tissue activation. XXI. Regulation of glycisaminoglycan metabolism by lymphocytes (CTAP-1) and platelet (CTAP-III) growth factors. In Vitro Cell Dev Biol 1981; 17: 777-85.
17. Castor CW, Prince RK, Dorstewitz EL. Characteristics of human fibroblasts cultivated in vitro from different anatomical sites. Lab Invest 1962; 11: 703-13.
18. Yaron I, Shirazi E, Yudovich R, Caspi D, Levartovsky D, Yaron M. Fluoxetine and amitriptilline inhibit nitric oxide, prostaglandin E2 and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum 1999; 42: 2561-8.
19. Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. An improved colorimetric assay for cell proliferation and viability using the tetrazolium salt XTT. J Immunol Methods 1991; 142; 257-65.
20. Yokota K, Miyoshi F, Miyzaki T, et al. High concentration simvastatin induces apoptosis in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Rheumatol 2008; 35: 193-200.
21. Yim HW, Jong HS, Choi HH, et al. Cyclooxygenase-2 inhibits novel ginseng metabolite - mediated apoptosis. Cancer Res 2005; 65: 1952-60.
22. Pawlik A, Baskiewicz-Masiuk M, Machalinski B, Gawronska-Szklarz B. The effect of methotrexate and glucocorticosteroids on apoptosis of phythemaglutinin-stimulated mononuclear cells from peripheral blood. Fundam Clin Pharmacol 2005; 19: 81-5.
23. Catrina AI, Trollmo C, af Klint E, et al. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis Rheum 2005; 52: 61-72.
24. Rubins JB, Greatens T, Kratzke RA, Tan AT, Polunovsky VA, Bitterman P. Lovastatin induces apoptosis in malignant mesothelioma cells. Am J Respir Crit Care Med 1998; 157: 1616-22.
25. Jones KD, Couldwell WT, Hinton DR, et al. Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem. Biophys Res Commun 1994; 205: 1681-7.
26. Vitale M, Di Matola T, Rossi G, Laezza C, Fenzi G, Bifulco M. Prenytransferase inhibitors induce apoptosis in proliferating thyroid cells through a p53-independent, CrmA-sensitive, and caspase-3 like protease dependent mechanism. Endocrinology 1999; 140: 698-704.
27. Wong WWL, Tan MM, Xia Z, Dimitroulakos J, Minden MD, Penn LZ. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin. Clin Cancer Res 2001; 7: 2067-75.
28. Van de Donk NWCJ, Kamphuis MM, Lokhorst HM, Bloem AC. The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells. Leukemia 2002; 16: 1362-71.
29. Tan A, Levrey H, Dahm C, Polunovsky VA, Rubins J, Bitterman PB. Lovastatin induces fibroblast apoptosis in vitro and in vivo. Apossible therapy for fibroproliferative disorders. Am J Respir Crit Care Med 1999; 159: 220-27.
30. Cafforio P, Dammacco F, Gernome A, Silvestris F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 2005; 26: 883-91.
31. Erl W, Hristov M, Neureuter M, Yan ZQ, Hansson GK, Weber PC. HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells. Atherosclerosis 2003; 169(2): 251-8.
32. Nagashima T, Okazaki H, Yudoh K, Matsuno H, Minota S. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation. Arthritis Rheum 2006; 54: 579-86.
33. Youssef S, Stuve O, Patarroyo JC, et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002; 420: 78-84.
34. Leung BP, Sattar N, Crilly A, et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003; 170(3): 1524-30.
35. Del Rincón I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.